To access this element change to forms mode OFF

Current Grant Opportunity View - GO5370

NHMRC-European Union Joint Programme - Neurodegenerative Disease Research (JPND) Call for Proposals 2022

Contact Details

NHMRC Research Help Centre

:
1800 500 983

:

:

GO ID:
GO5370
Agency:
National Health and Medical Research Council (NHMRC)
Close Date & Time:
29-Jun-2022 5:00 pm (ACT Local Time)
Show close time for other time zones
Internal Reference ID:
NHMRC-JPND Joint Call 2022
Primary Category:
231013 - Medical Research
Publish Date:
5-Jan-2022
Location:
ACT, NSW, VIC, SA, WA, QLD, NT, TAS
Selection Process:
Targeted or Restricted Competitive


Description:

NHMRC aims to provide assistance to Australian-based researchers who are participating as regular partners in multinational collaborative research projects that have been recommended for funding under the European Union-JPND Call for Proposals: “Understanding the mechanisms of non-pharmacological interventions” in the area of neurodegenerative disease.

JPND aims to tackle the challenge of neurodegenerative diseases and coordinate investment into research to find causes, develop cures, and identify appropriate ways to care for those with neurodegenerative diseases. The focus of this call is on improving the understanding of the mechanisms and biological substrates that underlie non-pharmacological interventions in order to tailor a holistic personalised treatment approach.

Eligibility:

To be eligible for funding under this grant opportunity Chief Investigators (CIs) listed as regular partners whose consortia have been invited by JPND to submit a full application may submit an application to NHMRC.

NHMRC will only fund applications with a key focus on one or several of the following neurodegenerative diseases, as identified in the JPND call text:

  • Alzheimer’s disease and other dementias
  • Parkinson’s disease and PD-related disorders
  • Prion diseases
  • Motor neuron diseases
  • Huntington’s disease
  • Spinocerebellar ataxia (SCA)
  • Spinal muscular atrophy (SMA).

Applying for funding with any other neurodegenerative disease research focus will not be supported by NHMRC for this grant opportunity.

Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institutions is available at:

https://www.nhmrc.gov.au/funding/manage-your-funding/funding-agreement-and-deeds-agreement

Applications must satisfy all requirements set out in the NHMRC-European Union Joint Programme: Understanding the mechanisms of non-pharmacological interventions Grant Guidelines. JPND documentation is available at:

https://www.neurodegenerationresearch.eu/initiatives/annual-calls-for-proposals/understanding-the-mechanisms-of-non-pharmacological-interventions/

Grant Activity Timeframe:

October 2022

Total Amount Available (AUD):

$2,000,000.00

Estimated Grant Value (AUD):

From $0.00 to $500,000.00

Instructions for Application Submission:

Applications must be submitted electronically using NHMRC’s online grants management system (Sapphire) unless otherwise advised by NHMRC.

Other Instructions:

The following information is specific to the NHMRC application process for Australian-based regular partners of consortia which have been invited to submit full applications by JPND:

  • The JPND secretariat will advise NHMRC of those invited to submit full applications.
  • NHMRC will then invite the relevant Australian researchers via email to submit applications for NHMRC funding through Sapphire.

Australian applicants must provide all documentation and budget requests as instructed in the Grant Guidelines document.

Contact Details

NHMRC Research Help Centre

:
1800 500 983

:

: